Skip to main content

Table 1 TIMING inclusion/exclusion criteria

From: Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial

Inclusion criteria

 

• Adult patients (aged ≥ 18 years) with acute ischemic stroke and atrial fibrillation

 

• Eligible and willing to start (or restart) NOAC

 

• Signed informed consent

 

Exclusion criteria

 

• Contraindication to NOAC (e.g. ongoing bleeding, mechanical heart valve prosthesis)

 

• Ongoing therapy with NOAC (without ≥ 2 days interruption at index stroke)

 

• INR > 1.7

 

• No second brain imaging (CT/MRI) after thrombolysis/thrombectomy

 

• Previous randomisation in the TIMING study

 
  1. NOAC non-vitamin K antagonist oral anticoagulant drugs, INR international normalised ratio, CT computed tomography, MRI magnetic resonance imaging